Pure Global
NCT05803161

Congrong Runtong Oral Liquid in the Treatment of Functional Constipation (Yang-deficiency Type)

A Randomized, Double-blind, Dose-exploration, Parallel-controlled, Multicenter Phase II Clinical Study of Congrong Runtong Oral Liquid in the Treatment of Functional Constipation (Yang-deficiency Type)
Beijing Hospital of Traditional Chinese Medicine·Phase 2·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Functional Constipation
Drug/Device/Intervention
Congrong Runtong oral liquid
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Beijing Hospital of Traditional Chinese Medicine
Timeline & enrollment
Phase
Phase 2
Start date
Apr 01, 2023
End date
Jun 30, 2025
Enrollment
180 participants
Primary outcome

Complete Spontaneous Bowel Movement (CSBM) response rate within 8 weeks of treatment

Summary

Using a placebo as a control, this study aims to preliminarily evaluate the clinical efficacy
 of Congrong Runtong oral liquid for the treatment of functional constipation (Yang-deficiency
 type), explore the optimal dosage of Congrong Runtong oral liquid for functional constipation
 (Yang-deficiency type) to provide a basis for dosage selection in Phase III clinical trials,
 and observe the safety of clinical use of Congrong Runtong oral liquid.

ICD-10 classifications
ConstipationOther functional intestinal disordersFunctional intestinal disorder, unspecifiedOther specified functional intestinal disordersOther laxatives
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05803161
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05803161 through Pure Global AI's free database. This Phase 2 trial is sponsored by Beijing Hospital of Traditional Chinese Medicine and is currently Not yet recruiting. The study focuses on Functional Constipation. Target enrollment is 180 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.